Extensively Drug-Resistant Carbapenemase-Producing Pseudomonas aeruginosa and Medical Tourism from the United States to Mexico, 2018-2019

Authors :: Kracalik, Ian
Ham, D. Cal
McAllister, Gillian
Smith, Amanda R.
Vowles, Maureen
Kauber, Kelly
Zambrano, Melba
Rodriguez, Gretchen
Garner, Kelley
Chorbi, Kaitlyn
Cassidy, P. Maureen
McBee, Shannon
Stoney, Rhett J.
Moser, Kathleen
Villarino, Margarita E.
Zazueta, Oscar E.
Bhatnagar, Amelia
Sula, Erisa
Stanton, Richard A.
Brown, Allison C.
Halpin, Alison L.
Epstein, Lauren
Walters, Maroya Spalding
Source :: Emerging Infectious Diseases. January, 2022, Vol. 28 Issue 1, p51, 11 p.
Publication Year :: 2022
Abstract: In the United States, 20% of Pseudomonas aeruginosa from adult device-associated healthcare-associated infections and 9% from surgical site infections are not susceptible to carbapenem antimicrobial drugs (1). However, only 1%-3% [...]

Subjects :: Epidemics -- Statistics -- Risk factors -- United States -- Mexico
Pseudomonas aeruginosa infections -- Risk factors -- Statistics
Drug resistance in microorganisms -- Statistics
Cross infection -- Statistics -- Risk factors
Obesity -- Surgery
Nosocomial infections -- Statistics -- Risk factors
Hospital patients -- Statistics
Medical tourism -- Statistics
Health

Full Text Access

Tools